Poolbeg Pharma PLC

6.05pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:POLBHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 5Y CAGR (10.33%)
Div yield —
ROE (58.55%)
Biotechnology
Beta (5Y) 1.82
PE TTM —
TSR TTM 62.63%
Mkt cap £46.19M
ROIC (40.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
6.43p
6.35%
(63.78%)
Hold 1|9|3|3|4
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.09
0.09
0.10
0.10
23.76%
12.47%
16.03%
14.01%
Revenue£M
2.869
2.792
2.720
2.866
3.52%
(4.04%)
(5.35%)
2.02%
Peers (US$62.15M)
Cap (US$)
PE
61.95M
—
Capital
TTM
5Y
10Y
Leveragex
1.230
(0.029)
(0.015)
EBIT/Intx
0.602
0.136
0.130
Own earn%
(39.50)
(246.32)
(224.56)
Sh yield%
19.99
15.33
16.84
Owners
Insiders/Inst%
5.56
81.12
Short interest%
5.57
SBC / revenue%
4.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
11–14
$1 testx
0.5
Incr. ROIC%
6